HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolongation of sickle cell survival by dimethyl adipimidate is compromised by immune sensitization.

Abstract
The effect of dimethyl adipimidate (DMA), an amino-reactive crosslinking reagent with demonstrated antisickling properties in vitro, on the survival of 51Cr-labeled autologous sickle cells was evaluated in five adult males with sickle cell anemia. The survival of cells pretreated with 5 mmol/L DMA (pH 7.4), normal (t1/2 28-33 days) in four subjects and near-normal (t1/2 20 days) in the fifth, was considerably longer than that usually observed in sickle cell disease. In fact, the effect of DMA on the survival of sickle cells in vivo equals or exceeds that of any other agent tested to date. In three subjects, the survival of a second infusion of DMA-treated red cells was much shorter (t1/2 1.8, 3, 4.5 days) than in the initial study. An antibody was detected in the serum of these subjects that was directed to DMA-treated red cells. Modification of the immunogenicity of treated cells will be required before further consideration of DMA for use in the therapy of sickle cell anemia.
AuthorsM S Guis, W M Lande, N Mohandas, R Pennathur-Das, H Preisler, B H Lubin, W C Mentzer
JournalBlood (Blood) Vol. 64 Issue 1 Pg. 161-5 (Jul 1984) ISSN: 0006-4971 [Print] United States
PMID6733268 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Imidoesters
  • Dimethyl Adipimidate
Topics
  • Adult
  • Anemia, Sickle Cell (drug therapy)
  • Antibody Formation
  • Desensitization, Immunologic
  • Dimethyl Adipimidate (adverse effects, therapeutic use)
  • Drug Hypersensitivity (etiology)
  • Erythrocyte Aging (drug effects)
  • Humans
  • Imidoesters (adverse effects)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: